Skip to main content
. 2020 Feb 20;10:3009. doi: 10.1038/s41598-020-59514-1

Figure 1.

Figure 1

Product-limit survival estimates over 10 years of observation of adjuvant chemotherapy-treated TNBC patients based on combined HER3-EGFR (top), HER3 (middle), and EGFR (bottom) protein expression. (A) Breast cancer-specific survival. (B) Distant metastasis-free survival.